Article Details

Pfizer's hemophilia B gene therapy succeeds in late-stage study - PharmaLive

Retrieved on: 2022-12-30 04:34:19

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's hemophilia B gene therapy succeeds in late-stage study - PharmaLive. View article details on hiswai:

Excerpt

The disorder hampers the body's ability to make a blood-clotting protein called factor IX. Pfizer's therapy, fidanacogene elaparvovec, is designed to ...

Article found on: www.pharmalive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up